New safety program to monitor Medicare drug use
AP/Yahoo News, May 23, 2008
Federal health officials will begin monitoring prescription drug usage by Medicare participants in an effort to identify potential safety problems. New regulations will enable the FDA, states and academic researchers to screen the Medicare claims data. The FDA primarily relies on physicians and patients to report suspected adverse events, and it often takes a number of cases before someone at the agency detects a pattern that's worth investigating. But now at the first hint of trouble, the FDA now will be able to query databases involving tens of millions of patients.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Handshaking Spreads Germs. Get Over It.
- Healthcare Costs Start With What We Eat
- Hospitals Likely to Outsource ICD-10 at Launch
- IOM Identifies GME Problems, Calls for Finance Changes
- CMS Confirms ICD-10 Deadline
- Anatomy of 3 Health System Rebranding Efforts
- Premium Subsidy Fight Creating Uncertainty for Hospitals, Health Plans
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts